. 2020 Dec 4;63:103154. doi: 10.1016/j.ebiom.2020.103154

Table 1.

Patient characteristics and treatments

	COVID-19 ARDS	Non-COVID-19 ARDS	p value
Number of patients (n)	28	12	-
Males/females (n)	20/8	6/6	0•28
Age (years)	61 [55-72]	72 [54-79]	0•75
Body weight (kg)	80•0 [66•6-87•6]	86•5 [65•3-94•1]	0•71
Height (cm)	170 [164-175]	173 [169-175]	0•55
Body mass index (kg/m²)	26•3 [23•7-32•4]	28•9 [23•0-30•9]	0•79
SAPS II score in the first 24 hours	62 [49-68]	46 [40-57]	0•051
SOFA score in the first 24 hours	11 [7-12]	8 [5-12]	0•37
Comorbidities: (n (%))
26- high blood pressure	11 (39)	6 (50)	0•73
26- chronic obstructive pulmonary disease	2 (7)	1 (8)	>0•99
26- ischemic cardiac disease	5 (18)	3 (25)	0•68
26- cancer	2 (7)	3 (25)	0•15
Treatments before admission: (n (%))
26- glucocorticoids	1 (4)	3 (25)	0•073
26- conversion enzyme inhibitors	5 (18)	1 (8)	0•54
26- angiotensin antagonists	2 (7)	2 (16)	0•57
Interventions after admission: (n (%))
26- catecholamines	17 (61)	4 (33)	0•17
26- renal replacement therapy	9 (32)	0 (0)	0•038
Treatments after admission: (n (%))
26- hydroxychloroquine	27 (96)	1 (8)	<0•0001
26- remdesivir	2 (7)	0 (0)	>0•99
26- lopinavir/ritonavir	7 (25)	0 (0)	0•081
26- glucocorticoids	11 (39)	6 (50)	0•73
26- fludrocortisone	1 (4)	4 (33)	0•022
26- eculizumab	12 (43)	4 (33)	0•73
Body temperature at first sample (°C)	37•4 [36•5-38•3]	37•3 [36•8-37•8]	0•84
Respiratory rate at first sample (breaths per min)	26 [25-28]	20 [18-23]	<0•0001
Tidal volume at first sample (mL)	420 [400-475]	438 [400-490]	0•99
Fraction of inspired oxygen at first sample (%)	80 [50-100]	48 [31-68]	0•007
Positive end-expiratory pressure at first sample (cm H₂O)	10 [8-13]	5•5 [5-8]	0•0002
Serum creatinine at first sample (µM)	74 [56-137]	67 [44-86]	0•30
Serum C-reactive protein at first sample (mg/L)	195 [175-268]	76 [23-119]	0•002

Continuous data are presented as the median [IQR].